Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 7 Decrease from baseline in the height of the inflection point of the digital volume pulse (IPDVP) after GTN (500 µg sublingually) and albuterol (ALB, 400 µg by inhalation through spacer) in patients with type II diabetes (n = 20) and control subjects (n = 20).
|
